Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hamilton James C
Chief Medical Officer at ARROWHEAD PHARMACEUTICALS. Filing since 5 Jan 2021.
CIK 0001830755
Company
Date
Role
Action
Shares
Amount
Of holding
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
23 Apr 2026
Chief Medical Officer
Sold on a plan
10,000
$750.00K
4.2%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Mar 2026
Chief Medical Officer
Sold on a plan
10,000
$641.90K
4.0%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2026
Chief Medical Officer
Sold on a plan
40,164
$2.53M
18.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
1 Oct 2025
Chief Medical Officer
Sold on a plan
20,000
$700.00K
8.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
12 Sep 2025
Chief Medical Officer
Sold on a plan
15,000
$450.00K
6.1%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
2 Sep 2025
Chief Medical Officer
Sold on a plan
15,000
$375.00K
5.7%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
15 Aug 2025
Chief Medical Officer
Sold on a plan
9,389
$187.78K
3.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
13 Aug 2025
Chief Medical Officer
Sold on a plan
611
$12.22K
0.2%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2025
Chief Discovery/Trans Medicine
Sold on a plan
32,729
$648.82K
10.7%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
1 Apr 2024
Chief Discovery/Trans Medicine
Sold at will
6,000
$168.18K
2.8%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
12 Jan 2024
Chief Discovery/Trans Medicine
Sold on a plan
7,940
$292.90K
3.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2024
Chief Discovery/Trans Medicine
Sold on a plan
32,143
$1.13M
12.8%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
3 Jan 2024
Chief Discovery/Trans Medicine
Sold on a plan
6,300
$202.78K
3.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
30 Jun 2023
Chief Discovery/Trans Medicine
Sold at will
3,000
$106.59K
1.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2023
Chief Discovery/Trans Medicine
Sold, plan not stated
13,803
$516.23K
6.7%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
3 Jan 2023
Chief Discovery/Trans Medicine
Sold, plan not stated
10,338
$396.74K
6.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2022
Senior Vice President
Sold, plan not stated
6,250
$385.77K
3.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
4 Jan 2022
Senior Vice President
Sold, plan not stated
19,375
$1.27M
10.7%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
14 Jan 2021
Senior Vice President
Sold, plan not stated
10,000
$812.94K
7.3%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2021
Senior Vice President
Sold, plan not stated
19,375
$1.40M
12.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2021
Senior Vice President
Sold, plan not stated
19,375
$1.41M
11.1%
21 decisions on file.
